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Ehrlichia chaffeensis, E. ewingii, E. muris and E. canis are known to cause febrile illnesses in humans
and dogs. These pathogens are transmitted by Ixodid ticks, including Amblyomma americanum,
Ixodes scapularis and Rhipicephalus sanguineus. Infection is established following ehrlichia invasion
of the human or dog white blood cells followed by general symptoms including headache, fever,
fatigue, and muscle aches. Ehrlichia chaffeensis infections of humans have a fatality rate up to 5%, or
higher in immunocompromised individuals.
Ehrlichiosis became a reportable disease in 1999. Since then, the number of reported cases has grown
exponentially, classifying ehrlichiosis as an emerging infectious disease. Ehrlichiosis caused by
Ehrlichia ewingii became a reportable disease in 2008.
Current Detection Methods
The first week of ehrlichial infections is a critical time span for proper diagnosis of infection and for
starting antibiotic treatment. Typically, hospitals use blood culturing methods for detection of
bacterial infections but this approach is not suitable for obligate intracellular bacteria such as
Ehrlichia. Ehrlichioses are diagnosed by PCR detection from a sample of whole blood during the
first week of infection. Analysis of a blood smear for morulae can suggest species specific detection;
E chaffeensis infects monocytes, whereas E. ewingii generally infects granulocytes. After the first
week of infection, anti-ehrlichia antibodies may become detectable. The indirect immunofluorescent
assay (IFA) for E. chaffeensis IgG is the primary detection method in hospitals for ehrlichiosis. The
downside to this test is the need for paired serum samples taken over multiple week periods. A
“positive” test for ehrlichiosis requires a 4 fold titer increase over 2-4 weeks of paired serum samples.
After infection, antibody levels may not decrease for months after treatment. Ehrlichia ewingii
displays antigenic cross-reactivity with E. chaffeensis, making the IFA test nonspecific and hard to
interpret when both agents are present in the same area. There is no specific serological test for E.
ewingii because this ehrlichia has not yet been cultivated.
Project Goals
Our project will develop approaches and tools to characterize the E. ewingii surface protein gene
homologous to the major 120 kDa (gp120) diagnostic protein antigen gene of E. chaffeensis using a
targeted RNA bait hybridization protocol.
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Figure 1: Increase in number of reported 
ehrlichiosis cases, Source: Centers for Disease 
Control. 
Figure 2: Distribution of reported ehrlichiosis cases by 
state, Source: Centers for Disease Control. 
Primers were designed using the OligoPerfect™ Designer from Thermo Fisher Scientific Inc.
for long-range tile amplification of 900-3,000 base pair fragments of E. chaffeensis
Five primer pairs were selected for full coverage of the gp120 gene. 
PCR conditions were optimized using Hot Start PCR to reduce non-specific amplification.
5 Amplified fragments were cloned into a linearized pMiniT™ vector and transformed into E. coli. 
PCR Amplification of 18 fragments gave only partial coverage of the target fragment.
Fig. 6. Agarose gel of PCR amplified fragments with E. chaffeensis primers. Each lane 
depicts the amplification product yielded with each primer pair tested. From left to right, 
Fragment 1 through Fragment 13, ladder, Fragment 14, 15, NTC: Negative Control. 
Numbers on the side of the gel correspond to the sizes of the 1Kb Plus DNA ladder.
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Fig. 8. Agarose gel of Hot Start PCR amplified fragments with E. chaffeensis
primers. From left to right, Fragment 4, 12, 13, 15, 18, NTC: Negative Control. 
Numbers on the side of the gel correspond to the sizes of the 1Kb Plus DNA ladder.
Individual clones were screened by PCR using plasmid flanking primers and fragment sizes 
were examined by agarose gel electrophoresis
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Fig. 15. Agarose gel of 10 individual clone colonies using E. chaffeensis
Fragment 12 primers. NTC: Negative Control. PTC: Positive Control. Numbers 
on the side of the gel correspond to the sizes of the 1Kb Plus DNA ladder.
Target fragments were re-amplified from selected clones and their identity 
was confirmed by Sanger sequencing.
Selected pairs will be used to produce biotinylated RNA baits.
Fig. 16. Schematic diagram of a capture hybridization assay using streptavidin beads and 
biotinylated RNA baits. Black and grey bars represent gene targets, and fully black bars represent 
unwanted background DNA.  Source: Summerer, D. 2009.
Biotinylated E.chaffeensis baits will be used in a capture hybridization assay using a streptavidin 
bead pull down method to separate the E. ewingii gene targets from unwanted background DNA.
Captured DNA will be purified and sequenced for characterization of the E. ewingii gp120 gene.
More primers were designed to achieve full coverage of the target fragment..
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Fig. 7. Agarose gel of Hot Start PCR amplified fragments with E. chaffeensis
primers. From left to right, Fragment 4, 6, 7, 9, 16, 17, 18, NTC: Negative Control. 
Numbers on the side of the gel correspond to the sizes of the 1Kb Plus DNA ladder.
Figure 4: E. chaffeensis morulae in 
the cytoplasm of a human monocyte.
Morulae is indicated by an arrow. 
Source: Centers for Disease Control. 
Figure 5: E. ewingii morulae in the 
cytoplasm of a neutrophil. Morulae is 
indicated by an arrow. Source: 
Centers for Disease Control. 
Figure 3: Life stages of Amblyomma americanum, 
a vector of ehrlichiosis. Source: Tick Encounter 
Resource Center, University of Rhode Island. 
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Fig. 13.  Reaction 15 
clones at 1:10000 
dilution.
Fig. 12.  Fragment 13 
clones at 1:10000 
dilution.
Fig. 10.  Fragment 4  
clones at 1:10000 
dilution.
Fig. 11.  Fragment 12 
clones at 1:10000 
dilution.
Fig. 14.  Reaction 18 
clones at 1:10000 
dilution.
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Fig. 9. Schematic diagram of E. chaffeensis gp120 gene and flanking genes 
and mapping of overlapping fragments for making capture baits. 
The map is not to scale. 
